YU44413B - Process for obtaining particles of matter soluble in lipoids and biologcally active substances adsorbed thereon - Google Patents

Process for obtaining particles of matter soluble in lipoids and biologcally active substances adsorbed thereon

Info

Publication number
YU44413B
YU44413B YU3290/80A YU329080A YU44413B YU 44413 B YU44413 B YU 44413B YU 3290/80 A YU3290/80 A YU 3290/80A YU 329080 A YU329080 A YU 329080A YU 44413 B YU44413 B YU 44413B
Authority
YU
Yugoslavia
Prior art keywords
biologcally
lipoids
active substances
substances adsorbed
obtaining particles
Prior art date
Application number
YU3290/80A
Other languages
English (en)
Other versions
YU329080A (en
Inventor
Z Riedl
L Sztankov
I Horvath
Original Assignee
Human Oltoanyagtermelo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Oltoanyagtermelo filed Critical Human Oltoanyagtermelo
Publication of YU329080A publication Critical patent/YU329080A/xx
Publication of YU44413B publication Critical patent/YU44413B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
YU3290/80A 1979-12-27 1980-12-26 Process for obtaining particles of matter soluble in lipoids and biologcally active substances adsorbed thereon YU44413B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79HU299A HU184141B (en) 1979-12-27 1979-12-27 Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof

Publications (2)

Publication Number Publication Date
YU329080A YU329080A (en) 1984-04-30
YU44413B true YU44413B (en) 1990-08-31

Family

ID=10997378

Family Applications (1)

Application Number Title Priority Date Filing Date
YU3290/80A YU44413B (en) 1979-12-27 1980-12-26 Process for obtaining particles of matter soluble in lipoids and biologcally active substances adsorbed thereon

Country Status (21)

Country Link
US (1) US4396630A (fr)
JP (1) JPS57112334A (fr)
BE (1) BE886884A (fr)
CA (1) CA1165237A (fr)
CH (1) CH655246A5 (fr)
CS (1) CS241478B2 (fr)
DD (1) DD158738A5 (fr)
DE (1) DE3048815A1 (fr)
DK (1) DK160288C (fr)
ES (1) ES498048A0 (fr)
FR (1) FR2472386B1 (fr)
GB (1) GB2066203B (fr)
HU (1) HU184141B (fr)
IT (1) IT1150073B (fr)
NL (1) NL8007041A (fr)
PL (1) PL228755A1 (fr)
PT (1) PT72261B (fr)
RO (1) RO81371A (fr)
SE (1) SE453537B (fr)
SU (1) SU1487802A3 (fr)
YU (1) YU44413B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4598051A (en) * 1980-03-12 1986-07-01 The Regents Of The University Of California Liposome conjugates and diagnostic methods therewith
US4806466A (en) * 1981-10-29 1989-02-21 The Regents Of The University Of California Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
WO1987002576A1 (fr) * 1985-10-31 1987-05-07 Kv Pharmaceutical Company Systemes de liberation d'agents actifs dans le vagin
DD247570A3 (de) * 1983-01-14 1987-07-15 Univ Berlin Humboldt Vesikulaeres trenn-, fuell- und traegermaterial
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US4619904A (en) * 1984-10-29 1986-10-28 General Electric Company Agglutinating immunoassay using protein-coated liquid droplets
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US4790987A (en) * 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
CA1338736C (fr) * 1986-12-05 1996-11-26 Roger Baurain Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
WO1990001947A1 (fr) * 1988-08-25 1990-03-08 The Liposome Company, Inc. Vaccin a affinite associee
ATE118096T1 (de) * 1988-12-22 1995-02-15 Baxter Diagnostics Inc Lipohaptene und verwendung trägergebundener lipohaptene im immuntest.
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
JPH07113641B2 (ja) * 1989-11-17 1995-12-06 積水化学工業株式会社 梅毒診断試薬の製造方法
NL9000207A (fr) * 1990-01-29 1991-08-16 Duphar Int Res
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
ES2138588T3 (es) * 1990-06-29 2000-01-16 Chiron Corp Composiciones de vacunas que contienen liposomas.
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
WO1992004887A1 (fr) * 1990-09-25 1992-04-02 Kyowa Hakko Kogyo Co., Ltd. Production de lymphocites t cytotoxiques
US6048531A (en) * 1991-04-15 2000-04-11 Albany Medical College Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
US5336507A (en) * 1992-12-11 1994-08-09 Sterling Winthrop Inc. Use of charged phospholipids to reduce nanoparticle aggregation
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
AUPM500494A0 (en) * 1994-04-12 1994-05-05 Minister For Agriculture & Rural Affairs For The State Of New South Wales, The Composition for use in increasing mucosal immunity
EP1355634B8 (fr) * 2000-11-09 2009-03-04 Neopharm, Inc. Complexes lipidiques a base de sn-38 et procedes d'utilisation
WO2003030864A1 (fr) * 2001-05-29 2003-04-17 Neopharm, Inc. Formulation liposomale d'irinotecan
US20030224039A1 (en) * 2002-03-05 2003-12-04 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex
AU2003296897A1 (en) * 2002-08-20 2004-05-04 Neopharm, Inc. Pharmaceutical formulations of camptothecine derivatives
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
AU2003304204B2 (en) * 2002-10-29 2009-12-24 Insmed Incorporated Sustained release of antiinfectives
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
WO2006090816A1 (fr) * 2005-02-25 2006-08-31 Mie University Procédé de fabrication de vaccin au liposome
US8226975B2 (en) 2005-12-08 2012-07-24 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US20150272880A1 (en) 2012-05-21 2015-10-01 Insmed Incorporated Systems for treating pulmonary infections
EP2925298B1 (fr) 2012-11-29 2019-05-29 Insmed Incorporated Formulations de vancomycine stabilisées
EP3466432B1 (fr) 2014-05-15 2020-07-08 Insmed Incorporated Méthodes de traitement d'infections pulmonaires mycobactériennes non-tuberculeuses
WO2019191627A1 (fr) 2018-03-30 2019-10-03 Insmed Incorporated Procédés pour la fabrication continue de produits médicamenteux liposomaux

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
JPS5126213A (ja) * 1974-08-21 1976-03-04 Tanabe Seiyaku Co Johoseibiryushiseizaino seiho
GB1564500A (en) * 1975-09-29 1980-04-10 Wellcome Found Biological preparations
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
IT1110989B (it) * 1979-01-19 1986-01-13 Erba Farmitalia Forme farmaceutiche costitutite da liposomi e procedimenti relativi
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPS55118415A (en) * 1979-02-28 1980-09-11 Pii Papahadojiyopo Dometoriosu Method of encapsulating biologically active substance in lipoid cell

Also Published As

Publication number Publication date
SU1487802A3 (ru) 1989-06-15
FR2472386B1 (fr) 1985-08-23
CA1165237A (fr) 1984-04-10
DE3048815A1 (de) 1981-09-10
HU184141B (en) 1984-07-30
DK552280A (da) 1981-06-28
IT8026950A0 (it) 1980-12-24
RO81371A (fr) 1984-04-02
PT72261B (en) 1981-11-05
CH655246A5 (de) 1986-04-15
YU329080A (en) 1984-04-30
RO81371B (ro) 1983-11-02
SE8009068L (sv) 1981-06-28
ES8201316A1 (es) 1981-12-16
CS241478B2 (en) 1986-03-13
NL8007041A (nl) 1981-07-16
DK160288C (da) 1991-08-05
IT1150073B (it) 1986-12-10
PT72261A (en) 1981-01-01
ES498048A0 (es) 1981-12-16
DK160288B (da) 1991-02-25
SE453537B (sv) 1988-02-08
JPS57112334A (en) 1982-07-13
GB2066203B (en) 1984-01-11
CS924680A2 (en) 1985-07-16
JPH0314814B2 (fr) 1991-02-27
US4396630A (en) 1983-08-02
FR2472386A1 (fr) 1981-07-03
PL228755A1 (fr) 1982-02-15
BE886884A (fr) 1981-06-29
DD158738A5 (de) 1983-02-02
GB2066203A (en) 1981-07-08

Similar Documents

Publication Publication Date Title
YU44413B (en) Process for obtaining particles of matter soluble in lipoids and biologcally active substances adsorbed thereon
GB2053176B (en) Spherical particles of activated carbon suitable for use in a pharmaceutical composition
DE3071169D1 (en) Apparatus for measurement of body substances and enzyme implants for use therein
HU179657B (en) Process for preparing esterasthine and pharmaceutical compositions containing such active substances
IL56252A (en) Pressure-resistant polyurethanepolyurea particles for the encapsulation of active ingredients and process for their manufacture
JPS55163057A (en) Powdered fireeextinguishing substance and its preparation
DE2965280D1 (en) Preparations of clotrimazole and process for preparing same
PT77060A (en) Process for preparing derivatives of morpholinyl daunorubicin and morpholinyl-doxorubicin and analogues thereof
CA1020037A (fr) Methode et materiel de manutention de l'etoupe dans la fabrication des cartouches filtrantes de fumee de tabac faites de particules
PT76809A (en) Process for preparing 1-sulfo-2-oxoazetidine derivatives and of pharmaceutical compositions containing the same
GB2137584B (en) Process and apparatus for the transport of powdered or particulate material
PT76657B (en) Process for preparing 4-aryl-4-piperidinecarbinols and of pharmaceutical compositions containing the same
JPS53138186A (en) Method of distributing and carrying solid bodies in powdered state
PT74654B (en) Process for the preparation of compositions in powder form containing pesticides and suitable for treatment of house hold furnishing
PT79026A (en) Improvements in or relating to containers and methods of and apparatus for manufacturing containers
ZA793740B (en) Method and apparatus for distributing pulverulent or particulate materials
JPS552589A (en) Method of and apparatus for conveying particle
GB2014712A (en) Method of and apparatus for distributing liquid fuel in fluidized bed
GB2052008B (en) Methods of and apparatus for conveying substances
SU632941A1 (ru) Способ контрол дисперсности частиц в суспензи х
HU173463B (hu) Sposob poluchenija 1-metil-2-/fenil-oksimetil/-5-nitro-imidazola i lechebnykh preparatov soderzhahhikh takoe aktivnoe vehhestvo
HUT34020A (en) Process for preparing new cyano-guanidine derivatives and pharmaceutical compositions containing such derivatives as active substances
PT77730B (en) Process for preparing acridanone derivatives and of pharmaceutical compositions containing the same
PT76166A (en) Process for the preparation of nasal pharmaceutical compositions containing dihydroergotamine and cafeine
JPS51124890A (en) Spherical binding grinding material made of grinding particles and method of manufacturing same